title: Limited tryptic modification stimulates activation of Ca2+ release from isolated sarcoplasmic reticulum vesicles.
abstract: Tryptic modification appears to potentiate activation of the Ca2+ channels of isolated sarcoplasmic reticulum vesicles. In the presence of 1 mM free Mg2+ we observe that: 1) cAMP and doxorubicin activation of passive efflux from tryptically modified vesicles is approximately 20-fold greater than from native SR. 2) Ruthenium red inhibits Ca2+ efflux from modified vesicles. 3) The binding affinities and Hill coefficients of activation of efflux by cAMP and doxorubicin are the same in modified vesicles as in native vesicles. 4) Proteolysis stimulates passive efflux from heavy SR much more than from light SR. 5) Stimulation of cAMP- and doxorubicin-activated Ca2+ release is biphasic, whereas Hg2+-activated Ca2+ efflux is monophasic. 6) In the absence of Mg2+, the Ca2+ dependence of cAMP-activated efflux from tryptically modified vesicles is similar to that of native vesicles, with peak efflux rates occurring between approximately 1 and 10 microM Ca2+. 7) The Mg2+ dependence of efflux from modified vesicles is similar to that of native vesicles. 8) SDS-polyacrylamide gels indicate that the Ca2+, Mg2+-ATPase and the high molecular weight ryanodine receptor are both cleaved faster than the stimulation of efflux.
authors.affiliation: Department of Physics, Portland State University, Oregon 97207.
authors.forename: J L
authors.initials: JL
authors.lastname: Trimm
authors.forename: G
authors.initials: G
authors.lastname: Salama
authors.forename: J J
authors.initials: JJ
authors.lastname: Abramson
mesh_terms: D000818:Animals; D002118:Calcium / Q000378:metabolism*; D015220:Calcium Channels / Q000187:drug effects / Q000378:metabolism*; D004317:Doxorubicin / Q000494:pharmacology; D007700:Kinetics; D008274:Magnesium / Q000494:pharmacology; D008628:Mercury / Q000494:pharmacology; D009132:Muscles / Q000378:metabolism; D010539:Permeability; D011817:Rabbits; D012016:Reference Values; D012519:Sarcoplasmic Reticulum / Q000187:drug effects / Q000378:metabolism*; D014357:Trypsin / Q000494:pharmacology*
chemical_list: D015220:Calcium Channels; D004317:Doxorubicin; D014357:Trypsin; D008628:Mercury; D008274:Magnesium; D002118:Calcium